EUVIMEDEUVIMED entdecken
Crossref

False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis

Jordan Franklin, Jody Hayes, Emily Knippa, Başak Dogan

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07259-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Jordan Franklin und 3 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Southwestern Medical Center Medical School, Dallas, TX, USA. jordanfranklin66@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, False Negative Reactions, Diagnostic Errors, Mammography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Mitigating false negative imaging studies remains an important issue given its association with worse morbidity and mortality in patients with breast cancer. We aimed to identify risk factors that predispose to false negative breast imaging exams. METHODS: In an IRB-approved, HIPAA compliant retrospective study, we identified all patients who were diagnosed with breast cancer within 365 days of a negative imaging study assessed as BI-RADS 1-3 between January 1, 2014 and January 31, 2020. A matched cohort based on mammographic breast density was created from randomly selected studies with BI-RADS 4-5 designation that yielded breast cancer at pathology within the same time frame. Patient and cancer characteristics, prior personal history of breast cancer and gene mutation status were collected from patient charts. Pearson chi-squared and Student's t-test on two independent groups with significance at < 0.05 was used for statistical analysis. RESULTS: We identified 155 false negative studies of 129 missed cancers and 128 breast density matched true positive cancers. False negative studies were screening mammograms in 57.42% (89/155), diagnostic mammograms in 29.68% (46/155), ultrasounds in 6.45% (10/155) and MRIs in 6.45% (10/155). Rates of personal (41.09% vs. 18.75%, p < 0.001) and family history of breast cancer (68.22% vs. 49.21%, p = 0.002) were higher in the false negative cohort and remained significant when asymptomatic MRI-detected cancers were removed. CONCLUSION: Our findings suggest that supplemental screening may be useful in breast cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFalse Negative ReactionsDiagnostic ErrorsMammographyMagnetic Resonance ImagingUltrasonography, MammaryRisk FactorsTime FactorsCohort StudiesHumansFemaleMiddle AgedAdultAgedAged, 80 and overImaging, Three-Dimensional

Stichwörter der Autor:innen

Breast MRIBreast cancerBreast cancer surveillanceFalse negativeMammographyScreening

Autor:innen und Institutionen

  • The University of Texas Southwestern Medical Center Medical School, Dallas, TX, USA. jordanfranklin66@gmail.com.
  • Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. jordanfranklin66@gmail.com.
  • Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Zitieren

APA

Franklin, J., Hayes, J., Knippa, E., & Dogan, B. (2024). False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07259-0

Vancouver

Franklin J, Hayes J, Knippa E, Dogan B. False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07259-0

BibTeX
@article{Franklin2024,
  author = {Franklin, Jordan and Hayes, Jody and Knippa, Emily and Dogan, Başak},
  title = {False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07259-0}
}
Kostenlos starten →